Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Automated Image Analysis for High-Throughput Single Molecule Analysis of Biomolecules

Project description

High-throughput single molecule analysis

Scanning probe microscopy (SPM) is an imaging technique that uses a needle-like tip to visualise structures of molecules on surface. This opens an exciting possibility to reveal many molecular structures of therapeutically relevant biomolecules that no techniques could access today. Despite this, structural determination using SPM is very time-consuming due to the many manual tasks involved in interpreting the SPM image. The ERC-funded Virgil project aims to eliminate these manual tasks by building a software that converts SPM images into molecular structures. This key innovation is expected to enable faster and more accurate single-molecule analysis while advancing structural biology, drug discovery and personalised medicine.

Objective

Project Virgil aims to revolutionize single-molecule analysis by developing automated, high-throughput image-to-structure software for scanning probe microscopy (SPM) images. This innovative technology addresses a critical bottleneck in biomolecular research: the low data throughput and time-consuming manual interpretation of SPM images. Building on recent breakthroughs in direct SPM imaging of single biomolecules, Project Virgil aims to create a parallel-computing program to interpret SPM images of individual macrobiomolecules into atomic-level structures. The software aims to be stable, versatile, and scalable, capable of analyzing a wide range of biomolecules up to few hundred thousands of atoms. Key activities include building the base program, implementing parallel computing, developing an IP strategy, and formulating a commercialization plan. Project Virgil main innovation lies in enabling first-time access to many previously inaccessible (bio)chemical structures and providing a single molecule analysis platform that far exceeds current manual capabilities. By enabling high-throughput single-molecule analysis, Project Virgil has significant potential across structural biology, pharmaceuticals, and biotechnology sectors, in reducing costs, accelerating drug discovery, and advancing personalized medicine. Project Virgil combines cutting-edge science with strategic commercialization planning, aiming to translate innovative research into a commercially viable product with significant impact on single molecule analysis. This project has the potential to reinforce European technological leadership and open new avenues for tackling important scientific and societal challenges at the single molecule level.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 150 000,00
Address
HOFGARTENSTRASSE 8
80539 MUNCHEN
Germany
Region
Berlin Berlin Berlin
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)